Prevotella intermedia | Fusobacterium nucleatum | P. intermedia + F. nucleatum | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Presence | Absence | OR (95% CI) | Presence | Absence | OR (95% CI) | Co-existence | Others | OR (95% CI) | ||
Gender | Male | 14 | 54 | 1.30 (0.50, 3.39) | 34 | 34 | 1.40 (0.66, 2.95) | 13 | 55 | 2.03 (0.67, 6.14) |
Female | 8 | 40 | 20 | 28 | 5 | 43 | ||||
Location | Left | 14 | 61 | 0.95 (0.36, 2.49) | 32 | 43 | 0.64 (0.30, 1.38) | 14 | 61 | 2.12 (0.65, 6.94) |
Right | 8 | 33 | 22 | 19 | 4 | 37 | ||||
TNM stage | Late (III/IV) | 12 | 37 | 2.05 (0.79, 5.35) | 28 | 21 | 2.19 (1.03, 4.64) | 11 | 38 | 2.89 (0.99, 8.48) |
Early (0/I/II) | 9 | 57 | 25 | 41 | 6 | 60 | ||||
Primary tumor | T3/T4 | 16 | 69 | 0.97 (0.34, 2.77) | 40 | 45 | 1.08 (0.47, 2.46) | 14 | 71 | 1.33 (0.40, 4.40) |
T0/T1/T2 | 6 | 25 | 14 | 17 | 4 | 27 | ||||
Lymph node | Yes | 12 | 37 | 2.05 (0.79, 5.35) | 28 | 21 | 2.19 (1.03, 4.64) | 11 | 38 | 2.89 (0.99, 8.48) |
Involvement | No | 9 | 57 | 25 | 41 | 6 | 60 | |||
Distant metastasis | Yes | 4 | 5 | 3.96 (0.97,16.19) | 7 | 2 | 4.47 (0.89, 22.51) | 4 | 5 | 5.31 (1.27, 22.20) |
No | 18 | 89 | 47 | 60 | 14 | 93 | ||||
CIN status | High | 13 | 46 | 1.75 (0.57, 5.41) | 29 | 30 | 0.97 (0.42, 2.21) | 12 | 47 | 2.04 (0.60, 6.90) |
Low or stable | 5 | 31 | 18 | 18 | 4 | 32 | ||||
Chr20 amplification | Yes | 12 | 54 | 0.85 (0.29, 2.55) | 30 | 36 | 0.59 (0.24, 1.42) | 11 | 55 | 0.96 (0.30, 3.06) |
No | 6 | 23 | 17 | 12 | 5 | 24 | ||||
Chr13q amplification | Yes | 12 | 37 | 2.16 (0.74, 6.35) | 27 | 22 | 1.60 (0.71, 3.59) | 11 | 38 | 2.37 (0.75, 7.46) |
No | 6 | 40 | 20 | 26 | 5 | 41 | ||||
MSI status | High | 3 | 5 | 2.76 (0.59, 12.83) | 6 | 2 | 3.15 (0.60, 16.49) | 3 | 5 | 3.28 (0.70, 15.42) |
Low or stable | 15 | 69 | 41 | 43 | 13 | 71 | ||||
APC mutation | Yes | 9 | 35 | 0.96 (0.33, 2.81) | 19 | 25 | 0.50 (0.21, 1.20) | 7 | 37 | 0.71 (0.23, 2.18) |
No | 8 | 30 | 23 | 15 | 8 | 30 | ||||
KRAS mutation | Yes | 7 | 24 | 1.20 (0.40, 3.55) | 17 | 14 | 1.26 (0.52, 3.09) | 5 | 26 | 0.79 (0.24, 2.57) |
No | 10 | 41 | 25 | 26 | 10 | 41 | ||||
TP53 mutation | Yes | 13 | 42 | 1.78 (0.52, 6.09) | 28 | 27 | 0.96 (0.38, 2.42) | 13 | 42 | 3.87 (0.81, 18.58) |
No | 4 | 23 | 14 | 13 | 2 | 25 |